Beckman Coulter Maintenance

The Naval Medical Logistics Command intends to negotiate, on behalf of the Drug Demand Reduction Program labs, on a sole source basis (IAW FAR 13.501 with Beckman Coulter Inc., 250 S Kraemer Blvd, Brea CA 92821, as the only sole source to conduct maintenance, warranty or service work on clinical chemistry analyzers model numbers AU5810, AU5820, and AU5830, as not to void the OEM warranty. The equipment is located at  Navy Drug Screening Laboratory, Great Lakes, IL; Navy Drug Screening Laboratory, Jacksonville, FL; Navy Drug Screening Laboratory, San Diego, CA; Army Forensic Toxicology Drug Testing Laboratory, Fort Meade, MD; Army Forensic Toxicology Drug Testing Laboratory, Tripler Army Medical Center, HI; and  Headquarters Air Force Drug Testing Laboratory, Lackland Air Force Base, TX. 

This acquisition is being conducted under simplified procedures for certain Commercial Items FAR 13.501. There are not set-aside restrictions for this requirement.  The intended procurement will be classified under North America industry Classification System (NAICS) 811219 with a Small Business Size Standard of $22,000,000.00.  This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement.  However, parties interested in responding to this notice will need to submit technical data, including cost, sufficient to determine capability in providing the same product.  All capability statements received by the closing date of this synopsis will be considered by the Government.  A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government.  Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

Capability statements shall be submitted by email only as a MS Word or Adobe PDF attachment to Jan Harding, Jan.t.harding.civ@mail.mil  by 9 AM ET on 13 February 2021.  No phone calls accepted.